Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | -2.22% | -3.72% | +5.77% |
Mar. 26 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Mar. 26 | Check-Cap Shares Soar on Merger Deal With Fintech Firm Nobul | MT |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 16.75 | 11.46 | 14.22 | 21.27 | 65.04 | 12.81 |
Enterprise Value (EV) 1 | 9.7 | -2.79 | 6.955 | 3.865 | 14.62 | -27.93 |
P/E ratio | -1.55 x | -0.82 x | -0.99 x | -1.01 x | -3.25 x | -0.65 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -0.99 x | 0.26 x | -0.5 x | -0.28 x | -0.85 x | 1.42 x |
EV / FCF | -1.74 x | 0.43 x | -0.87 x | -0.47 x | -1.36 x | 2.31 x |
FCF Yield | -57.4% | 232% | -115% | -214% | -73.3% | 43.3% |
Price to Book | 2.84 x | 0.88 x | 2.28 x | 1.3 x | 1.28 x | 0.31 x |
Nbr of stocks (in thousands) | 80.2 | 266 | 413 | 2,312 | 4,820 | 5,824 |
Reference price 2 | 208.8 | 43.00 | 34.40 | 9.200 | 13.49 | 2.200 |
Announcement Date | 4/4/18 | 3/28/19 | 3/6/20 | 3/18/21 | 4/6/22 | 3/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -9.844 | -10.64 | -13.95 | -13.78 | -17.12 | -19.69 |
EBIT 1 | -10 | -10.78 | -14.07 | -13.93 | -17.32 | -20.03 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -9.765 | -10.59 | -13.84 | -13.85 | -17.2 | -19.11 |
Net income 1 | -9.771 | -10.59 | -13.84 | -13.85 | -17.2 | -19.11 |
Net margin | - | - | - | - | - | - |
EPS 2 | -134.3 | -52.19 | -34.65 | -9.124 | -4.155 | -3.369 |
Free Cash Flow 1 | -5.569 | -6.476 | -7.974 | -8.278 | -10.71 | -12.09 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/4/18 | 3/28/19 | 3/6/20 | 3/18/21 | 4/6/22 | 3/31/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -3.557 | -3.923 | -4.263 | -5.578 | -5.885 | -4.888 | -5.045 | -4.215 | -4.85 | -6.063 | -2.863 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -3.566 | -3.918 | -4.241 | -5.477 | -5.834 | -4.807 | -4.754 | -3.713 | -4.442 | -6.878 | -2.59 |
Net income 1 | -3.566 | -3.918 | -4.241 | -5.477 | -5.834 | -4.807 | -4.754 | -3.713 | -4.442 | -6.878 | -2.59 |
Net margin | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -1.000 | -1.200 | -0.8000 | -1.200 | -1.200 | -0.8000 | -0.8000 | -0.6350 | -0.7600 | -1.180 | -0.4400 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 5/12/21 | 8/5/21 | 11/3/21 | 4/6/22 | 6/1/22 | 8/31/22 | 11/30/22 | 3/31/23 | 5/11/23 | 8/4/23 | 11/27/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 7.05 | 14.2 | 7.26 | 17.4 | 50.4 | 40.7 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -5.57 | -6.48 | -7.97 | -8.28 | -10.7 | -12.1 |
ROE (net income / shareholders' equity) | -120% | -112% | -144% | -122% | -51.3% | -41.5% |
ROA (Net income/ Total Assets) | -61.9% | -57.7% | -70.7% | -59.9% | -28.8% | -24.8% |
Assets 1 | 15.79 | 18.34 | 19.56 | 23.11 | 59.82 | 77.14 |
Book Value Per Share 2 | 73.60 | 48.90 | 15.10 | 7.080 | 10.50 | 7.070 |
Cash Flow per Share 2 | 87.20 | 32.20 | 18.60 | 3.330 | 5.490 | 0.7000 |
Capex 1 | 0.23 | 0.09 | 0.17 | 0.38 | 1.01 | 0.49 |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 4/4/18 | 3/28/19 | 3/6/20 | 3/18/21 | 4/6/22 | 3/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+5.77% | 12.87M | |
-16.10% | 11.41B | |
-30.20% | 2.3B | |
-14.31% | 2.16B | |
-26.03% | 1.56B | |
+36.95% | 1.19B | |
-2.40% | 760M | |
-19.00% | 506M | |
-38.57% | 444M | |
+13.72% | 339M |
- Stock Market
- Equities
- CHEK Stock
- Financials Check-Cap Ltd.